Dana-Farber Cancer Institute at Foxborough — Foxborough, Massachusetts

Dana-Farber Cancer Institute at Foxborough is a clinical research site located in Foxborough, Massachusetts, United States 02035.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute at Foxborough has participated in 17 clinical trials with 17 currently active.

Therapeutic areas: Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8, Endometrial Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, Dana-Farber Cancer Institute, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Foxborough

Browse all research sites in Massachusetts · View every site in Foxborough

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute at Foxborough?

Dana-Farber Cancer Institute at Foxborough has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute at Foxborough conducted?

Dana-Farber Cancer Institute at Foxborough has 17 clinical trials on record, with 17 currently active. Their work covers Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8, Endometrial Cancer.

Is Dana-Farber Cancer Institute at Foxborough accredited by Crixeo Clinical Trials?

Dana-Farber Cancer Institute at Foxborough has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute at Foxborough?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.